Related Experiment Video
Updated: Sep 2, 2025
08:20
A New Toolkit for Evaluating Gene Functions using Conditional Cas9 Stabilization
Published on: September 2, 2021
4.2K
Stimuli-responsive nanoformulations for CRISPR-Cas9 genome editing
Tianxu Fang1,2, Xiaona Cao1,2,3, Mysha Ibnat1,2
1Department of Biomedical Engineering, McGill University, Montreal, QC, H3G 0B1, Canada.
Journal of Nanobiotechnology
|August 2, 2022
Summary
Stimuli-responsive nanoplatforms offer advanced, non-viral delivery for CRISPR-Cas9 gene editing. These systems enhance precision and efficiency for treating genetic diseases.
Area of Science:
- Biotechnology and Nanomedicine
- Gene Editing Technologies
- Molecular Biology
Background:
- CRISPR-Cas9 technology has revolutionized genome editing, showing promise for treating genetic diseases.
- Efficient intracellular delivery of CRISPR-Cas9 components is crucial for its therapeutic application.
- Non-viral delivery systems are explored for their safety advantages over viral vectors.
Purpose of the Study:
- To review recent advancements in stimuli-responsive nanoformulations for CRISPR-Cas9 delivery.
- To highlight the design principles of stimuli and formulations for controlled gene editing.
- To summarize the biomedical applications of these advanced delivery systems.
Main Methods:
- Overview of various stimuli-responsive non-viral nanoplatforms for CRISPR-Cas9.
- Analysis of trigger mechanisms (biological cues, external stimuli) for controlled release.
- Examination of formulation strategies for enhanced delivery and editing efficiency.
Main Results:
- Stimuli-responsive nanoplatforms enable precise and efficient intracellular delivery of CRISPR-Cas9.
- These systems respond to specific triggers for targeted genome editing.
- Diverse biomedical applications are emerging for these advanced delivery technologies.
Conclusions:
- Stimuli-responsive nanoplatforms represent a significant breakthrough in CRISPR-Cas9 delivery.
- They offer a promising avenue for developing safer and more effective gene therapies.
- Continued research in formulation design and stimuli response will broaden their therapeutic potential.
Related Concept Videos
01:28CRISPR/Cas9 Genome Editing
182
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
182
01:59CRISPR
52.8K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
52.8K
02:53CRISPR and crRNAs
17.3K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.3K
02:31Homologous Recombination
50.9K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.9K